Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.18B | 6.70B | 6.65B | 5.00B | 3.64B | 3.39B | Gross Profit |
1.83B | 1.82B | 1.79B | 1.28B | 878.40M | 789.00M | EBIT |
715.00M | 740.00M | 775.00M | 425.00M | 185.50M | 155.00M | EBITDA |
890.00M | 894.00M | 924.00M | 511.00M | 319.00M | 293.00M | Net Income Common Stockholders |
410.00M | 371.00M | 581.00M | 225.00M | 37.00M | 36.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.00M | 1.00M | 177.00M | 1.00M | 380.90M | 180.90M | Total Assets |
4.43B | 5.07B | 4.91B | 4.43B | 3.59B | 3.20B | Total Debt |
1.62B | 2.07B | 1.63B | 1.62B | 2.39B | 2.15B | Net Debt |
1.62B | 2.07B | 1.46B | 1.62B | 2.01B | 1.97B | Total Liabilities |
2.60B | 3.54B | 2.50B | 2.60B | 2.92B | 2.56B | Stockholders Equity |
1.32B | 1.45B | 1.75B | 1.32B | 673.90M | 641.50M |
Cash Flow | Free Cash Flow | ||||
651.00M | 1.03B | 376.00M | -51.00M | 207.90M | 180.00M | Operating Cash Flow |
680.00M | 1.07B | 401.00M | -31.00M | 219.80M | 194.00M | Investing Cash Flow |
-845.00M | -270.00M | -152.00M | -203.00M | -228.90M | -234.00M | Financing Cash Flow |
74.00M | -975.00M | -73.00M | -146.00M | 209.10M | 184.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $20.07B | 37.37 | 20.39% | 2.11% | 4.59% | -2.05% | |
77 Outperform | $44.12B | 37.30 | 33.04% | 2.08% | 2.71% | -0.63% | |
74 Outperform | $9.84B | 23.32 | 23.84% | ― | 8.24% | 1.25% | |
65 Neutral | $2.89B | 20.89 | 10.37% | ― | 3.71% | -49.38% | |
64 Neutral | $743.72M | 37.86 | -1.00% | 3.20% | -9.98% | -106.51% | |
63 Neutral | $12.25B | 28.84 | 33.41% | 1.44% | -4.16% | -15.44% | |
62 Neutral | $8.36B | 14.28 | 2.39% | 3.06% | 3.99% | -14.45% |